Health Care & Life Sciences » Biotechnology | Kiwa Bio-Tech Products Group Corp.

Kiwa Bio-Tech Products Group Corp. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
2.00
3.00
0.50
13.50
1,083.50
7.90
Total Accounts Receivable
14.50
-
33.90
1,161.70
92.10
7,086.60
Inventories
-
-
-
-
15,406.80
17,406.20
Other Current Assets
-
14.30
16.60
3,297.60
2,474.30
2,259.60
Total Current Assets
16.50
17.20
51.00
4,472.70
19,056.70
26,760.20
Net Property, Plant & Equipment
12.00
7.40
-
55.30
90.50
93.20
Total Investments and Advances
-
-
-
34.50
840.70
-
Long-Term Note Receivable
-
-
12.20
1,522.40
-
-
Other Assets
-
-
-
-
16.70
5,657.60
Total Assets
28.50
24.60
63.20
6,085.00
20,004.60
32,511
ST Debt & Current Portion LT Debt
150.30
150.30
510.30
510.30
633.20
Accounts Payable
321.70
-
18.40
1,233.60
1,800.60
Income Tax Payable
-
-
-
415.00
1,143.00
Other Current Liabilities
7,964.50
8,811.10
10,634.90
8,170.30
5,296.90
Total Current Liabilities
8,436.40
8,961.30
11,163.60
10,329.00
8,873.70
Long-Term Debt
1,899.70
1,871.10
-
-
460.10
Total Liabilities
10,336.00
10,832.50
11,163.60
10,329.00
9,333.80
Common Equity (Total)
10,307.60
10,807.90
11,101.00
4,244.60
10,669.50
Total Shareholders' Equity
10,307.60
10,807.90
11,100.50
4,244.10
10,670.80
Total Equity
10,307.60
10,807.90
11,100.50
4,244.10
10,670.80
Liabilities & Shareholders' Equity
28.50
24.60
63.20
6,085.00
20,004.60
Preferred Stock (Carrying Value)
-
-
0.50
0.50
1.30

About Kiwa Bio-Tech Products Group

View Profile
Address
3200 Guasti Road
Ontario California 91761
United States
Employees -
Website http://www.kiwabiotech.com
Updated 07/08/2019
Kiwa Bio-Tech Products Group Corp. engages in the development, manufacture, and distribution of environmentally safe bio-technological products for agriculture. Its products are bio-fertilizers, biological enhanced livestock feed, animal drugs and disinfectants. Kiwa Bio-Tech Products Group uses AF-01 anti-viral aerosol technology for veterinary medicine applications.